XML 36 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Equity Incentive Plans (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Option Activity

A summary of option activity under the 2019 Plan, 2024 Plan and the Inducement Plan is as follows:

 

 

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price Per
Share

 

 

Weighted-
Average
Remaining
Contractual
Term (in
years)

 

 

Aggregate
Intrinsic
Value
(in
thousands)

 

Outstanding at December 31, 2023 *

 

 

4,310,034

 

 

$

4.09

 

 

 

9.09

 

 

$

11,810

 

Options granted

 

 

3,539,804

 

 

$

8.29

 

 

 

 

 

 

 

Options exercised *

 

 

(420,290

)

 

$

3.15

 

 

 

 

 

 

 

Options forfeited

 

 

(312,739

)

 

$

10.18

 

 

 

 

 

 

 

Options expired

 

 

(4,031

)

 

$

4.42

 

 

 

 

 

 

 

Outstanding at September 30, 2024

 

 

7,112,778

 

 

$

5.97

 

 

 

7.52

 

 

$

2,854

 

Exercisable at September 30, 2024 **

 

 

1,851,204

 

 

$

3.55

 

 

 

6.43

 

 

$

2,486

 

Vested and expected to vest at September 30, 2024

 

 

7,112,778

 

 

$

5.97

 

 

 

7.52

 

 

$

2,854

 

Schedule of Fair Value of Options Granted to Employees and Nonemployees Estimated using Black-Scholes Valuation Model using the Assumptions

The fair value of options granted was estimated using the Black-Scholes valuation model using the following assumptions for the three and nine months ended September 30, 2024 and 2023, respectively:

 

 

 

Three Months Ended September 30

 

Nine Months Ended September 30,

 

 

2024

 

2023

 

2024

 

2023

 

 

 

 

 

 

 

 

 

Expected volatility

 

92.9%-94.0%

 

91% - 92%

 

92.9%-94.0%

 

91% - 95%

Expected dividend yield

 

0%

 

0%

 

0%

 

0%

Expected term (in years)

 

5.77-6.08

 

5.9 - 6.1

 

5.77-6.08

 

5.9 - 6.1

Risk-free interest rate

 

3.5%-4.4%

 

3.9%

 

3.5%-4.4%

 

3.9%

Schedule of Stock-based Compensation Expense

The following table presents the classification of stock-based compensation expense related to stock options granted (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

 

$

966

 

 

$

195

 

 

$

2,243

 

 

$

445

 

General and administrative

 

 

2,447

 

 

 

326

 

 

 

4,732

 

 

 

991

 

Total stock-based compensation expense

 

$

3,413

 

 

$

521

 

 

$

6,975

 

 

$

1,436